NCT06360484View on ClinicalTrials.gov

Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

September 1, 2022

Study Completion Date

September 10, 2022

Conditions
Hepatitis BHepatitis DViral Hepatitis
Interventions
DIAGNOSTIC_TEST

investigations for Hepatitis D virus

Investigations included liver function tests, abdominal ultrasounds to identify features of chronic liver disease, and evidence of decompensation. ELISA for Ant-HDV-IgG was conducted.

Trial Locations (1)

15004

National Center for Gastrointestinal and Liver Diseases, Khartoum

All Listed Sponsors
lead

National Center for Gastroentestinal and Liver Disease

OTHER

NCT06360484 - Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus | Biotech Hunter | Biotech Hunter